Mark Grajcar
Family Medicine · Meridian, IDNPI 1669416137
Payments from drug & device makers
Across 185 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$715
- AstraZeneca$408
- Boehringer Ingelheim$393
- Novo Nordisk$260
- Pfizer$249
- Corcept Therapeutics$191
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,390100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $715 |
| AstraZeneca | 20 | $408 |
| Boehringer Ingelheim | 13 | $393 |
| Novo Nordisk | 15 | $260 |
| Pfizer | 14 | $249 |
| Corcept Therapeutics | 9 | $191 |
| Lilly USA, LLC | 9 | $152 |
| GSK | 6 | $103 |
| Arbor Pharmaceuticals, Inc. | 6 | $95 |
| Johnson & Johnson | 6 | $94 |
| Amgen(2 entities) | 6 | $84 |
| Bayer | 4 | $82 |
| Merck | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Abbott | 2 | $43 |
| Corium, LLC | 2 | $43 |
| Organon | 2 | $32 |
| Mylan Specialty L.p. | 2 | $29 |
| Eisai Inc. | 2 | $28 |
| Stryker | 1 | $24 |
| QOL Medical, LLC | 3 | $23 |
| Novartis | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Exact Sciences | 1 | $22 |
| Recor Medical Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Exeltis, USA Inc. | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Medtronic | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $12 |
How this compares
$3,390 in reported general payments places this provider in the 90th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 16 | $30,227 |
| EliquisApixaban | 20 | $25,705 |
| OzempicSemaglutide | 20 | $22,804 |
| JardianceEmpagliflozin | 12 | $13,682 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $11,072 |
| Levothyroxine Sodium | 74 | $897 |
| Gabapentin | 28 | $880 |
| Celecoxib | 19 | $845 |
| Omeprazole | 37 | $750 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $634 |
| Duloxetine Hcl | 30 | $594 |
| Atorvastatin Calcium | 50 | $512 |
| Rosuvastatin Calcium | 60 | $472 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 17 | $394 |
| Carvedilol | 22 | $315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $260 | $53,03136 claims |
| PfizerEliquis | $249 | $25,70520 claims |
| Boehringer IngelheimJardiance | $393 | $13,68212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 803 family medicine providers in Idaho.
Other family medicine in Meridian
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Elaine DavidsonMeridian$303K
- Timothy McHughMeridian$176K
- Mark JohnsonMeridian$10K
- Jason LudwigMeridian$7K
- Jacob SmithMeridian$7K
- Ginger AllenMeridian$6K
- George ThomasMeridian$6K
- Aaron MoorhouseMeridian$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.